CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...